Profiling PI3K-AKT-MTOR variants in focal brain malformations reveals new insights for diagnostic care
Open accessPublished version of a preprint
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Focal malformations of cortical development including focal cortical dysplasia, hemimegalencephaly and megalencephaly, are a spectrum of neurodevelopmental disorders associated with brain overgrowth, cellular and architectural dysplasia, intractable epilepsy, autism and intellectual disability. Importantly, focal cortical dysplasia is the most common cause of focal intractable paediatric epilepsy. Gain and loss of function variants in the PI3K-AKT-MTOR pathway have been identified in this spectrum, with variable levels of mosaicism and tissue distribution. In this study, we performed deep molecular profiling of common PI3K-AKT-MTOR pathway variants in surgically resected tissues using droplet digital polymerase chain reaction (ddPCR), combined with analysis of key phenotype data. A total of 159 samples, including 124 brain tissue samples, were collected from 58 children with focal malformations of cortical development. We designed an ultra-sensitive and highly targeted molecular diagnostic panel using ddPCR for six mutational hotspots in three PI3K-AKT-MTOR pathway genes, namely PIK3CA (p.E542K, p.E545K, p.H1047R), AKT3 (p.E17K) and MTOR (p.S2215F, p.S2215Y). We quantified the level of mosaicism across all samples and correlated genotypes with key clinical, neuroimaging and histopathological data. Pathogenic variants were identified in 17 individuals, with an overall molecular solve rate of 29.31%. Variant allele fractions ranged from 0.14 to 22.67% across all mutation-positive samples. Our data show that pathogenic MTOR variants are mostly associated with focal cortical dysplasia, whereas pathogenic PIK3CA variants are more frequent in hemimegalencephaly. Further, the presence of one of these hotspot mutations correlated with earlier onset of epilepsy. However, levels of mosaicism did not correlate with the severity of the cortical malformation by neuroimaging or histopathology. Importantly, we could not identify these mutational hotspots in other types of surgically resected epileptic lesions (e.g. polymicrogyria or mesial temporal sclerosis) suggesting that PI3K-AKT-MTOR mutations are specifically causal in the focal cortical dysplasia-hemimegalencephaly spectrum. Finally, our data suggest that ultra-sensitive molecular profiling of the most common PI3K-AKT-MTOR mutations by targeted sequencing droplet digital polymerase chain reaction is an effective molecular approach for these disorders with a good diagnostic yield when paired with neuroimaging and histopathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies employing deep targeted sequencing in resected brain tissue highlight the role of brainrestricted somatic mosaic variants in nearly all of these genes in FCD type II, sometimes with hemimegalencephaly 123 , with variant allele frequencies as low as 0.01% 130 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [130]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Blümcke, I., Thom, M., Aronica, E., Armstrong, D. D., Vinters, H. V., Palmini, A., Jacques, T. S., Avanzini, G., Barkovich, A. J., Battaglia, G., et al. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2010.02777.x · Cited by 1,743
Self-citationMultiplex Targeted Sequencing Identifies Recurrently Mutated Genes in Autism Spectrum Disorders
O’Roak, B. J., Vives, L., Fu, W., Egertson, J. D., Stanaway, I. B., Phelps, I. G., Carvill, G., Kumar, A., Lee, C., Ankenman, K., et al. (2012) · Science · doi:10.1126/science.1227764 · Cited by 1,240
Finding of Rare Disease Genes (FORGE) Canada Consortium, Rivière, J.-B., Mirzaa, G. M., O'Roak, B. J., Beddaoui, M., Alcantara, D., Conway, R. L., St-Onge, J., Schwartzentruber, J. A., Gripp, K. W., et al. (2012) · Nature Genetics · doi:10.1038/ng.2331 · Cited by 741
Self-citationDe novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly
Lee, J. H., Huynh, M., Silhavy, J. L., Kim, S., Dixon-Salazar, T., Heiberg, A., Scott, E., Bafna, V., Hill, K. J., Collazo, A., et al. (2012) · Nature Genetics · doi:10.1038/ng.2329 · Cited by 703
Luks, V. L., Kamitaki, N., Vivero, M. P., Uller, W., Rab, R., Bovée, J. V. M. G., Rialon, K. L., Guevara, C. J., Alomari, A. I., Greene, A. K., et al. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.12.069 · Cited by 583
Self-citationMultiplexed genotyping with sequence-tagged molecular inversion probes
Hardenbol, P., Banér, J., Jain, M., Nilsson, M., Namsaraev, E. A., Karlin-Neumann, G. A., Fakhrai-Rad, H., Ronaghi, M., Willis, T. D., Landegren, U., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt821 · Cited by 559
Tolerance of Droplet-Digital PCR vs Real-Time Quantitative PCR to Inhibitory Substances
Dingle, T. C., Sedlak, R. H., Cook, L., & Jerome, K. R. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.211045 · Cited by 374
Jansen, L. A., Mirzaa, G. M., Ishak, G. E., O'Roak, B. J., Hiatt, J. B., Roden, W. H., Gunter, S. A., Christian, S. L., Collins, S., Adams, C., et al. (2015) · Brain · doi:10.1093/brain/awv045 · Cited by 364
Self-citationDissecting the genetic basis of focal cortical dysplasia: a large cohort study
Baldassari, S., Ribierre, T., Marsan, E., Adle-Biassette, H., Ferrand-Sorbets, S., Bulteau, C., Dorison, N., Fohlen, M., Polivka, M., Weckhuysen, S., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02061-5 · Cited by 356
D'Gama, A. M., Geng, Y., Couto, J. A., Martin, B., Boyle, E. A., LaCoursiere, C. M., Hossain, A., Hatem, N. E., Barry, B. J., Kwiatkowski, D. J., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24357 · Cited by 290
Mirzaa, G. M., Campbell, C. D., Solovieff, N., Goold, C. P., Jansen, L. A., Menon, S., Timms, A. E., Conti, V., Biag, J. D., Olds, C., et al. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.0363 · Cited by 273
Self-citationQuantitation of the cellular content of saliva and buccal swab samples
Theda, C., Hwang, S. H., Czajko, A., Loke, Y. J., Leong, P., & Craig, J. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-25311-0 · Cited by 269
Ribierre, T., Deleuze, C., Bacq, A., Baldassari, S., Marsan, E., Chipaux, M., Muraca, G., Roussel, D., Navarro, V., Leguern, E., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99384 · Cited by 241
Sensitivity assessment of droplet digital PCR for SARS-CoV-2 detection
Falzone, L., Musso, N., Gattuso, G., Bongiorno, D., Palermo, C., Scalia, G., Libra, M., & Stefani, S. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4673 · Cited by 207
Zhu, G., Ye, X., Dong, Z., Lu, Y. C., Sun, Y., Liu, Y., McCormack, R., Gu, Y., & Liu, X. (2015) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2015.01.004 · Cited by 202
Najm, I. M., Sarnat, H. B., & Blümcke, I. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12462 · Cited by 196
Review: Mechanistic target of rapamycin (mTOR) pathway, focal cortical dysplasia and epilepsy
Marsan, E., & Baulac, S. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12463 · Cited by 191
Mirzaa, G., Timms, A. E., Conti, V., Boyle, E. A., Girisha, K. M., Martin, B., Kircher, M., Olds, C., Juusola, J., Collins, S., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.87623 · Cited by 185
Self-citationOegema, R., Barakat, T. S., Wilke, M., Stouffs, K., Amrom, D., Aronica, E., Bahi‐Buisson, N., Conti, V., Fry, A. E., Geis, T., et al. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0395-6 · Cited by 162
Self-citationDo, H., & Dobrovic, A. (2012) · Oncotarget · doi:10.18632/oncotarget.503 · Cited by 159
Megalencephaly and hemimegalencephaly: Breakthroughs in molecular etiology
Mirzaa, G., & Poduri, A. (2014) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31401 · Cited by 151
Self-citationDEPDC5 mutations in families presenting as autosomal dominant nocturnal frontal lobe epilepsy
Picard, F., Makrythanasis, P., Navarro, V., Ishida, S., de Bellescize, J., Ville, D., Weckhuysen, S., Fosselle, E., Suls, A., De Jonghe, P., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000488 · Cited by 146
Oral epithelial stem cells in tissue maintenance and disease: the first steps in a long journey
Jones, K. B., & Klein, O. D. (2013) · International Journal of Oral Science · doi:10.1038/ijos.2013.46 · Cited by 142
Focal Cortical Dysplasia: Gene Mutations, Cell Signaling, and Therapeutic Implications
Iffland, P. H., & Crino, P. B. (2017) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100138 · Cited by 142
Eijkelenboom, A., Kamping, E. J., Kastner-van Raaij, A. W., Hendriks-Cornelissen, S. J., Neveling, K., Kuiper, R. P., Hoischen, A., Nelen, M. R., Ligtenberg, M. J. L., & Tops, B. B. J. (2016) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2016.06.010 · Cited by 130
Alcantara, D., Timms, A. E., Gripp, K. W., Baker, L., Park, K., Collins, S., Cheng, C. V., Stewart, F., Mehta, S. G., Saggar, A. K., et al. (2017) · Brain · doi:10.1093/brain/awx203 · Cited by 128
Self-citationSalamon, N., Andres, M., Chute, D. J., Nguyen, S. T., Chang, J. W., Huynh, M. N., Chandra, P. S., Andre, V. M., Cepeda, C., Levine, M. S., et al. (2006) · Brain · doi:10.1093/brain/awh681 · Cited by 120
Mouse models of human PIK3CA-related brain overgrowth have acutely treatable epilepsy
Roy, A., Skibo, J., Kalume, F., Ni, J., Rankin, S., Lu, Y., Dobyns, W. B., Mills, G. B., Zhao, J. J., Baker, S. J., et al. (2015) · eLife · doi:10.7554/elife.12703 · Cited by 113
Self-citationOrigin of blood cells and HSC production in the embryo
Costa, G., Kouskoff, V., & Lacaud, G. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.01.012 · Cited by 112
Dobyns, W. B., & Mirzaa, G. (2019) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31736 · Cited by 103
Self-citationBlümcke, I., Coras, R., Busch, R. M., Morita‐Sherman, M., Lal, D., Prayson, R., Cendes, F., Lopes‐Cendes, I., Rogerio, F., Almeida, V. S., et al. (2021) · Epilepsia · doi:10.1111/epi.16899 · Cited by 96
Focal cortical dysplasia: an update on diagnosis and treatment
Guerrini, R., & Barba, C. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1915135 · Cited by 79
Self-citationMulti-focal occurrence of cortical dysplasia in epilepsy patients
Fauser, S., Sisodiya, S. M., Martinian, L., Thom, M., Gumbinger, C., Huppertz, H.-J., Hader, C., Strobl, K., Steinhoff, B. J., Prinz, M., et al. (2009) · Brain · doi:10.1093/brain/awp145 · Cited by 78
Uchiyama, Y., Nakashima, M., Watanabe, S., Miyajima, M., Taguri, M., Miyatake, S., Miyake, N., Saitsu, H., Mishima, H., Kinoshita, A., et al. (2016) · Scientific Reports · doi:10.1038/srep22985 · Cited by 77
Najm, I., Tilelli, C. Q., & Oghlakian, R. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01064.x · Cited by 75
Genotype correlates with clinical severity in PIK3CA-associated lymphatic malformations
Zenner, K., Cheng, C. V., Jensen, D. M., Timms, A. E., Shivaram, G. M., Bly, R. A., Ganti, S. N., Whitlock, K. B., Dobyns, W. B., Perkins, J. A., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.129884 · Cited by 65
Self-citationPrimary microcephaly: New approaches for an old disorder
Dobyns, W. B. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10580 · Cited by 63
Self-citationArvia, R., Sollai, M., Pierucci, F., Urso, C., Massi, D., & Zakrzewska, K. (2017) · Journal of Virological Methods · doi:10.1016/j.jviromet.2017.04.003 · Cited by 54
Genomic and Epigenetic Advances in Focal Cortical Dysplasia Types I and II: A Scoping Review
Jesus‐Ribeiro, J., Pires, L. M., Melo, J. D., Ribeiro, I. P., Rebelo, O., Sales, F., Freire, A., & Melo, J. B. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.580357 · Cited by 52
Ultra-Sensitive Droplet Digital PCR for the Assessment of Microchimerism in Cellular Therapies
Kliman, D. S., Castellano‐González, G., Withers, B., Street, J. A., Tegg, E. M., Mirochnik, O., Lai, J., Clancy, L. E., Gottlieb, D. J., & Blyth, E. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2017.12.802 · Cited by 51
Kuo, A. J., Paulson, V., Hempelmann, J. A., Beightol, M., Todhunter, S., Colbert, B. G., Salipante, S. J., Konnick, E. Q., Pritchard, C. C., & Lockwood, C. M. (2020) · Practical Laboratory Medicine · doi:10.1016/j.plabm.2020.e00153 · Cited by 51
Self-citationIs Focal Cortical Dysplasia/Epilepsy Caused by Somatic MTOR Mutations Always a Unilateral Disorder?
Guerrini, R., Cavallin, M., Pippucci, T., Rosati, A., Bisulli, F., Dimartino, P., Barba, C., Garbelli, R., Buccoliero, A. M., Tassi, L., et al. (2020) · Neurology Genetics · doi:10.1212/nxg.0000000000000540 · Cited by 35
Self-citationPaolis, E. D., Bonis, M. D., Concolino, P., Piermattei, A., Fagotti, A., Urbani, A., Scambia, G., Minucci, A., & Capoluongo, E. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.12.001 · Cited by 25
Targeted Capture and High-Throughput Sequencing Using Molecular Inversion Probes (MIPs)
Cantsilieris, S., Stessman, H. A. F., Shendure, J., & Eichler, E. E. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6442-0_6 · Cited by 24
Piacitelli, A. M., Jensen, D. M., Brandling‐Bennett, H. A., Gray, M. M., Batra, M., Gust, J., Thaker, A. I., Paschal, C. R., Tsuchiya, K. D., Pritchard, C. C., et al. (2018) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.40487 · Cited by 24
Self-citationBerra, C. M., Torrezan, G. T., de Paula, C. A., Hsieh, R., Lourenço, S. V., & Carraro, D. M. (2019) · Applied cancer research/Applied Cancer Research · doi:10.1186/s41241-019-0075-2 · Cited by 23
Cheng, Y. Y., Yuen, M. L., Rath, E. M., Johnson, B., Zhuang, L., Yu, T.-K., Aleksova, V., Linton, A., Kao, S., Clarke, C. J., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.579327 · Cited by 23
mTOR pathway activation in focal cortical dysplasia
Kumari, K., Sharma, M. C., Kakkar, A., Malgulwar, P. B., Pathak, P., Suri, V. S., Sarkar, C., Chandra, S. P., & Faruq, M. (2020) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2020.151523 · Cited by 20
Polymicrogyria in association with hypoglycemia points to mutation in the mTOR pathway
Stutterd, C., McGillivray, G., Stark, Z., Messazos, B., Cameron, F. J., White, S. M., Mirzaa, G., & Leventer, R. J. (2018) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2018.06.002 · Cited by 19
Self-citationCsernák, E., Molnár, J., Tusnády, G., et al. (2016) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000325 · Cited by 14
Lin, Y., Lin, K., Kang, D., Liu, X., Wang, X., Zheng, S., Yu, L., & Lin, Z. (2015) · Epilepsy Research · doi:10.1016/j.eplepsyres.2015.02.002 · Cited by 13
Tissue localization during resective epilepsy surgery
Poliachik, S. L., Poliakov, A. V., Jansen, L. A., McDaniel, S. S., Wray, C. D., Kuratani, J. D., Saneto, R. P., Ojemann, J. G., & Novotny, E. J. (2013) · Neurosurgical FOCUS · doi:10.3171/2013.3.focus1360 · Cited by 10
Self-citationHemimegalencephaly associated with contralateral hemispheral volume loss
Sener, R. N. (1995) · Pediatric Radiology · doi:10.1007/bf02021717 · Cited by 8
Cited by
Developmental and epileptic encephalopathies
Scheffer, I. E., Zuberi, S., Mefford, H. C., Guerrini, R., & McTague, A. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00546-6 · Cited by 158
Self-citationWang, S., Li, K., He, Q., Yang, H., Yang, Y., Wang, X., Shu, Y., & Ding, J. (2025) · Epilepsia · doi:10.1111/epi.18498 · Cited by 4
Metadata
- Authors
- Pirozzi, F., Berkseth, M., Shear, R., Gonzalez, L., Timms, A. E., Sulc, J., Pao, E., Oyama, N., Forzano, F., Conti, V., Guerrini, R., Doherty, E. S., Saitta, S. C., Lockwood, C. M., Pritchard, C. C., Dobyns, W. B., Novotny, E., Wright, J. N. N., Saneto, R. P., Friedman, S., Hauptman, J., Ojemann, J., Kapur, R. P., & Mirzaa, G. M.
- Affiliations
- Seattle Children's Research Institute (US)
- Johns Hopkins University (US)
- Center for Integrative Brain Research, Seattle Children’s Research Institute , Seattle, WA , USA
- King's College London (GB)
- Meyer Children's Hospital (IT)
- Carilion Clinic (US)
- University of California, Los Angeles (US)
- University of Minnesota (US)
- Seattle Children's Hospital (US)
- University of Washington (US)
- Corresponding author
- Mirzaa, Ghayda M
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2022-03-01
- Volume
- 145
- Issue
- 3
- Pages
- 925-938
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC9630661
- OpenAlex
- W4205911223
- Cited by
- 54
- References
- 53
- Citations by year
- 2026: 6 · 2025: 14 · 2024: 12 · 2023: 18 · 2022: 4
- FWCI
- 8.39
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- Locations
- Brain (publishedVersion)
- medRxiv (acceptedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Florence Research (University of Florence) (submittedVersion)
- Funders
- Brotman-Baty Institute
- Jordan’s Guardian Angels and the Sunderland Foundation
- Tuscany Region
- NIH (1R01NS092772)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Fetal and Pediatric Neurological Disorders
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- focal cortical dysplasia, hemimegalencephaly, megalencephaly, somatic mosaicism, variant allele frequency, mutational hotspots, drug-resistant epilepsy, droplet digital PCR
- MeSH terms
- Drug Resistant Epilepsy, Brain, Child, Epilepsy, Humans, Mutation, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt, Malformations of Cortical Development, Class I Phosphatidylinositol 3-Kinases, TOR Serine-Threonine Kinases, Hemimegalencephaly
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.